| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-16 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.35 | 5e-12 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-11 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-08 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |